Inhibiting Fibroblast Mechanotransduction Modulates Severity of Idiopathic Pulmonary Fibrosis.

Artem A. Trotsyuk,Kellen Chen,Sun Hyung Kwon,Kun Cathy Ma,Dominic Henn,Alana M Mermin-Bunnell,Smiti Mittal,Jagannath Padmanabhan,Madelyn R Larson,Sydney R Steele,Dharshan Sivaraj,Clark A. Bonham,Chikage Noishiki,Melanie Rodrigues,Yuanwen Jiang,Serena Jing,Simiao Niu,Arhana Chattopadhyay,David P. Perrault,Melissa C. Leeolou,Katharina Fischer,Gurupranav Gurusankar,Hudson Choi Kussie,Derrick C. Wan,Michael Januszyk,Michael T. Longaker,Geoffrey C. Gurtner

Inhibiting Fibroblast Mechanotransduction Modulates Severity of Idiopathic Pulmonary Fibrosis.

2021

Objective: Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease that affects 63 in every 100,000 Americans. Its etiology remains unknown, although inflammatory pathways appear...

Keywords:

lung disease
Fibroblast
Pathology
Etiology
Mechanotransduction
inflammatory pathways
Idiopathic pulmonary fibrosis
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations